In the past five years, ICON has conducted approximately 269 cardiovascular studies, involving over 151,519 patients at 11,524 sites worldwide.
Our clinical trial experience includes but is not limited to the following cardiovascular indications:
ICON has a global team of in-house Cardiovascular experts, known as a Therapeutic Area Group (TAG), who are highly-experienced in clinical research and drug development. The group includes representatives from all critical functional areas and oversees trial operations in order to anticipate and proactively address potential roadblocks. In addition to providing support and guidance to the study team, the other main responsibilities of the TAG teams include:
Our global investigator database includes over 2,800 cardiovascular investigative sites across more than 55 countries. As such, we have established solid working relationships with leading cardiovascular sites in all regions of the world, enabling us to provide our sponsors with efficient recruitment strategies tailored to each individual study. We have worked with a wealth of specialty investigators in multiple areas of cardiovascular disease.